
|Videos|July 20, 2012
Commonly Prescribed Acid Reflux Medication Not Helpful for Children With Asthma
Advertisement
Acid reflux is common among children with asthma, and in recent years there has been a dramatic increase in prescriptions of proton pump inhibitors (PPIs) for children with asthma. This episode of the JAMA Report discusses a controlled study in which pediatric asthma patients without acid reflux symptoms were given either placebo or a PPI in addition to corticosteroids. The study found that PPI treatment did not improve asthma symptoms and may come with risks, including increased chance of infection.
To read our article on the study, click
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Updates in Treatment of Unresectable Hepatocellular Carcinoma
2
Soaring off the Patent Cliff: Preparing for the Next Wave of Oncology Biosimilars
3
FDA Approves Depemokimab as Add-On Maintenance Treatment in Severe Asthma
4
Infliximab and Adalimumab Biosimilars Maintain Comparable Safety, Efficacy, Immunogenicity in IBD
5











































































































































































































